141 related articles for article (PubMed ID: 31563988)
1. Artemisinin suppresses hepatocellular carcinoma cell growth, migration and invasion by targeting cellular bioenergetics and Hippo-YAP signaling.
Li Y; Lu J; Chen Q; Han S; Shao H; Chen P; Jin Q; Yang M; Shangguan F; Fei M; Wang L; Liu Y; Liu N; Lu B
Arch Toxicol; 2019 Nov; 93(11):3367-3383. PubMed ID: 31563988
[TBL] [Abstract][Full Text] [Related]
2. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
[TBL] [Abstract][Full Text] [Related]
3. Tubuloside B, a major constituent of Cistanche deserticola, inhibits migration of hepatocellular carcinoma by inhibiting Hippo-YAP pathway.
Yao J; Wan H; Zhang J; Shen W; Wei X; Shi C; Ou B; Liu D; Ge L; Fei J; Zeng X
Phytomedicine; 2024 Jul; 129():155552. PubMed ID: 38552378
[TBL] [Abstract][Full Text] [Related]
4. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B
Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566
[TBL] [Abstract][Full Text] [Related]
5. SEPT6 drives hepatocellular carcinoma cell proliferation, migration and invasion via the Hippo/YAP signaling pathway.
Fan Y; Du Z; Ding Q; Zhang J; Op Den Winkel M; Gerbes AL; Liu M; Steib CJ
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33846777
[TBL] [Abstract][Full Text] [Related]
6. Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration.
Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
Biomed Pharmacother; 2020 Aug; 128():110366. PubMed ID: 32526459
[TBL] [Abstract][Full Text] [Related]
7. Decursin inhibits the growth of HepG2 hepatocellular carcinoma cells via Hippo/YAP signaling pathway.
Li J; Wang H; Wang L; Tan R; Zhu M; Zhong X; Zhang Y; Chen B; Wang L
Phytother Res; 2018 Dec; 32(12):2456-2465. PubMed ID: 30251417
[TBL] [Abstract][Full Text] [Related]
8. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
[TBL] [Abstract][Full Text] [Related]
9. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
[TBL] [Abstract][Full Text] [Related]
10. LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling.
Cheng Y; Hou T; Ping J; Chen T; Yin B
J Exp Clin Cancer Res; 2018 Sep; 37(1):228. PubMed ID: 30219064
[TBL] [Abstract][Full Text] [Related]
11. Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
Qian L; Liu Y; Xu Y; Ji W; Wu Q; Liu Y; Gao Q; Su C
Cancer Lett; 2015 Nov; 368(1):126-134. PubMed ID: 26259512
[TBL] [Abstract][Full Text] [Related]
12. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of AKT enhances the anti-cancer effects of Artemisinin in clear cell renal cell carcinoma.
Yu C; Sun P; Zhou Y; Shen B; Zhou M; Wu L; Kong M
Biomed Pharmacother; 2019 Oct; 118():109383. PubMed ID: 31545251
[TBL] [Abstract][Full Text] [Related]
14. TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma.
Dong Q; Fu L; Zhao Y; Xie C; Li Q; Wang E
Oncotarget; 2017 Feb; 8(9):15689-15703. PubMed ID: 28152516
[TBL] [Abstract][Full Text] [Related]
15. The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation.
Lin M; Zheng X; Yan J; Huang F; Chen Y; Ding R; Wan J; Zhang L; Wang C; Pan J; Cao X; Fu K; Lou Y; Feng XH; Ji J; Zhao B; Lan F; Shen L; He X; Qiu Y; Jin J
Nat Commun; 2024 Jun; 15(1):4995. PubMed ID: 38862474
[TBL] [Abstract][Full Text] [Related]
16. Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT.
Fan X; Song J; Zhao Z; Chen M; Tu J; Lu C; Wu F; Zhang D; Weng Q; Zheng L; Xu M; Ji J
Cancer Lett; 2019 Sep; 460():119-127. PubMed ID: 31207322
[TBL] [Abstract][Full Text] [Related]
17. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.
Zhang Y; Yan S; Chen J; Gan C; Chen D; Li Y; Wen J; Kremerskothen J; Chen S; Zhang J; Cao Y
J Cell Mol Med; 2017 Dec; 21(12):3718-3729. PubMed ID: 28815883
[TBL] [Abstract][Full Text] [Related]
18. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib inhibits hepatocellular carcinoma via the Hippo-Yes-associated protein signalling pathway.
Liao Y; Hu K; Liu W; Wang W; Qiu H; Pan S; Lv Q; Xu G
Basic Clin Pharmacol Toxicol; 2023 Apr; 132(4):297-311. PubMed ID: 36585038
[TBL] [Abstract][Full Text] [Related]
20. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T
Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
